Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1300 | 8578 | 45.3 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
66 | 3 | LEPTIN//ADIPONECTIN//ENDOCRINOLOGY & METABOLISM | 84415 |
1300 | 2 | THIAZOLIDINEDIONES//PPAR GAMMA//ROSIGLITAZONE | 8578 |
3093 | 1 | PIOGLITAZONE//THIAZOLIDINEDIONES//ROSIGLITAZONE | 2068 |
3123 | 1 | PPAR DELTA//PPAR BETA DELTA//PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | 2060 |
5985 | 1 | 15D PGJ2//15 DEOXY DELTA12 14 PROSTAGLANDIN J2//CYCLOPENTENONE PROSTAGLANDINS | 1547 |
9168 | 1 | PPAR GAMMA//PPAR RESEARCH//TROGLITAZONE | 1182 |
13971 | 1 | PRO12ALA POLYMORPHISM//PRO12ALA//PPAR GAMMA 2 | 801 |
15078 | 1 | TROGLITAZONE//JTT 501//CS 045 | 732 |
29356 | 1 | REPROD METAB//ADIPQ//AIB3 | 188 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THIAZOLIDINEDIONES | authKW | 1168075 | 8% | 50% | 657 |
2 | PPAR GAMMA | authKW | 876419 | 9% | 32% | 774 |
3 | ROSIGLITAZONE | authKW | 790211 | 6% | 43% | 513 |
4 | PIOGLITAZONE | authKW | 780932 | 6% | 43% | 505 |
5 | TROGLITAZONE | authKW | 554490 | 3% | 57% | 273 |
6 | PPAR RESEARCH | journal | 511736 | 3% | 54% | 265 |
7 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA | authKW | 447294 | 4% | 34% | 368 |
8 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | authKW | 437116 | 4% | 33% | 369 |
9 | PPAR | authKW | 371961 | 4% | 32% | 332 |
10 | PPAR DELTA | authKW | 197638 | 1% | 59% | 94 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 16992 | 18% | 0% | 1542 |
2 | Pharmacology & Pharmacy | 5415 | 17% | 0% | 1439 |
3 | Chemistry, Medicinal | 4827 | 8% | 0% | 661 |
4 | Medicine, Research & Experimental | 3338 | 8% | 0% | 723 |
5 | Peripheral Vascular Diseases | 2347 | 6% | 0% | 478 |
6 | Biochemistry & Molecular Biology | 1961 | 17% | 0% | 1436 |
7 | Cell Biology | 1436 | 9% | 0% | 739 |
8 | Oncology | 945 | 8% | 0% | 650 |
9 | Cardiac & Cardiovascular System | 802 | 5% | 0% | 439 |
10 | Biophysics | 363 | 4% | 0% | 301 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSE | 85787 | 1% | 31% | 78 |
2 | MOL TOXICOL CARCINOGENESIS | 50681 | 1% | 22% | 65 |
3 | FRONTIERS GENET | 38376 | 0% | 35% | 31 |
4 | U545 | 36184 | 1% | 23% | 44 |
5 | U325 | 21044 | 0% | 22% | 27 |
6 | REPROD METAB | 20719 | 0% | 45% | 13 |
7 | NUCL RECEPTOR DISCOVERY | 18015 | 0% | 30% | 17 |
8 | INTEGRAT GENOM | 16544 | 1% | 7% | 69 |
9 | LBRE | 16007 | 0% | 75% | 6 |
10 | VASC DIS PREVENT PROGRAM | 14227 | 0% | 67% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PPAR RESEARCH | 511736 | 3% | 54% | 265 |
2 | DIABETES OBESITY & METABOLISM | 12366 | 1% | 4% | 88 |
3 | METABOLISM-CLINICAL AND EXPERIMENTAL | 5308 | 1% | 1% | 117 |
4 | DIABETES | 5024 | 2% | 1% | 133 |
5 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3941 | 2% | 1% | 173 |
6 | DIABETES CARE | 3521 | 1% | 1% | 109 |
7 | DIABETES & VASCULAR DISEASE RESEARCH | 2519 | 0% | 4% | 17 |
8 | DIABETIC MEDICINE | 2294 | 1% | 1% | 62 |
9 | DIABETOLOGIA | 2156 | 1% | 1% | 73 |
10 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2145 | 1% | 1% | 69 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THIAZOLIDINEDIONES | 1168075 | 8% | 50% | 657 | Search THIAZOLIDINEDIONES | Search THIAZOLIDINEDIONES |
2 | PPAR GAMMA | 876419 | 9% | 32% | 774 | Search PPAR+GAMMA | Search PPAR+GAMMA |
3 | ROSIGLITAZONE | 790211 | 6% | 43% | 513 | Search ROSIGLITAZONE | Search ROSIGLITAZONE |
4 | PIOGLITAZONE | 780932 | 6% | 43% | 505 | Search PIOGLITAZONE | Search PIOGLITAZONE |
5 | TROGLITAZONE | 554490 | 3% | 57% | 273 | Search TROGLITAZONE | Search TROGLITAZONE |
6 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA | 447294 | 4% | 34% | 368 | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+GAMMA | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR+GAMMA |
7 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR | 437116 | 4% | 33% | 369 | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR | Search PEROXISOME+PROLIFERATOR+ACTIVATED+RECEPTOR |
8 | PPAR | 371961 | 4% | 32% | 332 | Search PPAR | Search PPAR |
9 | PPAR DELTA | 197638 | 1% | 59% | 94 | Search PPAR+DELTA | Search PPAR+DELTA |
10 | 15D PGJ2 | 172469 | 1% | 65% | 75 | Search 15D+PGJ2 | Search 15D+PGJ2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PETERS, JM , SHAH, YM , GONZALEZ, FJ , (2012) THE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS IN CARCINOGENESIS AND CHEMOPREVENTION.NATURE REVIEWS CANCER. VOL. 12. ISSUE 3. P. 181 -195 | 170 | 77% | 115 |
2 | PIRAT, C , FARCE, A , LEBEGUE, N , RENAULT, N , FURMAN, C , MILLET, R , YOUS, S , SPECA, S , BERTHELOT, P , DESREUMAUX, P , ET AL (2012) TARGETING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARS): DEVELOPMENT OF MODULATORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 9. P. 4027 -4061 | 156 | 92% | 55 |
3 | CHO, N , MOMOSE, Y , (2008) PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AGONISTS AS INSULIN SENSITIZERS: FROM THE DISCOVERY TO RECENT PROGRESS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 17. P. 1483 -1507 | 191 | 82% | 47 |
4 | MENENDEZ-GUTIERREZ, MP , ROSZER, T , RICOTE, M , (2012) BIOLOGY AND THERAPEUTIC APPLICATIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 6. P. 548 -584 | 242 | 59% | 16 |
5 | MICHALIK, L , AUWERX, J , BERGER, JP , CHATTERJEE, VK , GLASS, CK , GONZALEZ, FJ , GRIMALDI, PA , KADOWAKI, T , LAZAR, MA , O'RAHILLY, S , ET AL (2006) INTERNATIONAL UNION OF PHARMACOLOGY. LXI. PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 58. ISSUE 4. P. 726-741 | 174 | 62% | 418 |
6 | HAMBLIN, M , CHANG, L , FAN, YB , ZHANG, JF , CHEN, YE , (2009) PPARS AND THE CARDIOVASCULAR SYSTEM.ANTIOXIDANTS & REDOX SIGNALING. VOL. 11. ISSUE 6. P. 1415 -1452 | 232 | 58% | 72 |
7 | WILLSON, TM , BROWN, PJ , STERNBACH, DD , HENKE, BR , (2000) THE PPARS: FROM ORPHAN RECEPTORS TO DRUG DISCOVERY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 43. ISSUE 4. P. 527 -550 | 168 | 56% | 1213 |
8 | NEELS, JG , GRIMALDI, PA , (2014) PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR BETA.PHYSIOLOGICAL REVIEWS. VOL. 94. ISSUE 3. P. 795 -858 | 251 | 39% | 33 |
9 | HE, WM , (2009) PPAR GAMMA 2(PRO12ALA) POLYMORPHISM AND HUMAN HEALTH.PPAR RESEARCH. VOL. . ISSUE . P. - | 163 | 77% | 26 |
10 | KOSTAPANOS, MS , ELISAF, MS , MIKHAILIDIS, DP , (2013) PIOGLITAZONE AND CANCER: ANGEL OR DEMON?.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 27. P. 4913-4929 | 156 | 73% | 11 |
Classes with closest relation at Level 2 |